UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

British journal of cancer, 2013-04, Vol.108 (6), p.1358-1367

2013

Volltextzugriff (PDF)

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer

BMC cancer, 2020-09, Vol.20 (1), p.850-850, Article 850

2020

Volltextzugriff (PDF)

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

British journal of cancer, 2010-10, Vol.103 (8), p.1284-1291

2010

Volltextzugriff (PDF)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

British journal of cancer, 2014-08, Vol.111 (5), p.1004-1013

2014

Volltextzugriff (PDF)

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib

British journal of cancer, 2012-09, Vol.107 (6), p.947-955

2012

Volltextzugriff (PDF)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.937-947

2012

Volltextzugriff (PDF)

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients

Frontiers in oncology, 2021-06, Vol.11, p.697572-697572

2021

Volltextzugriff (PDF)

Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways

Oncogene, 2006-03, Vol.25 (9), p.1413-1419

2006

Volltextzugriff (PDF)

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

International journal of cancer, 2015-01, Vol.136 (1), p.91-97

2015

Volltextzugriff (PDF)

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.387-394

2011

Volltextzugriff (PDF)

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

British journal of cancer, 2009-12, Vol.101 (11), p.1824-1832

2009

Volltextzugriff (PDF)

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer

Scientific reports, 2018-06, Vol.8 (1), p.1-14, Article 9657

2018

Volltextzugriff (PDF)

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

British journal of cancer, 2008-10, Vol.99 (10), p.1644-1650

2008

Volltextzugriff (PDF)

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

Annals of oncology, 2015-03, Vol.26 (3), p.510-516

2015

Volltextzugriff (PDF)

A new approach for rapid and reliable enumeration of circulating endothelial cells in patients

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.931-939

2012

Volltextzugriff (PDF)

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

European journal of cancer (1990), 2009-01, Vol.45 (1), p.74-81

2009

Volltextzugriff (PDF)

mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy

Molecular oncology, 2016-12, Vol.10 (10), p.1542-1550

2016

Volltextzugriff (PDF)

Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro

Breast cancer research and treatment, 1999-05, Vol.55 (1), p.9-20

1999

Volltextzugriff (PDF)

Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue

Molecular oncology, 2007-09, Vol.1 (2), p.205-215

2007

Volltextzugriff (PDF)

Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro

Breast cancer research and treatment, 1998-09, Vol.51 (2), p.139-148

1998

Volltextzugriff (PDF)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer

JNCI : Journal of the National Cancer Institute, 2014-02, Vol.106 (2), p.djt376

2014

Volltextzugriff (PDF)

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer

Endocrine-related cancer, 2008-03, Vol.15 (1), p.101-111

2008

Volltextzugriff (PDF)

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

Journal of clinical oncology, 2006-04, Vol.24 (11), p.1665-1671

2006

Volltextzugriff (PDF)

Abstract P5-11-02: Recurrent ESR1 fusions in primary tumors; a promising predictive factor for outcome to first-line endocrine therapy?

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-11-02

2019

Volltextzugriff (PDF)

Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling

Journal of clinical oncology, 2005-02, Vol.23 (4), p.732-740

2005

Volltextzugriff (PDF)

1 – 25 von 246

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(234)
Mit Volltextzugriff
(230)

Publikationsform

Artikel
(245)
Tagungsberichte
(1)

Sprache

Englisch
(245)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients

Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients

A new approach for rapid and reliable enumeration of circulating endothelial cells in patients

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy

Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro

Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue

Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

Abstract P5-11-02: Recurrent ESR1 fusions in primary tumors; a promising predictive factor for outcome to first-line endocrine therapy?

Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling

Suchergebnisse filtern